Flumazenil CAS: 78755-81-4

CAS NO: 78755-81-4
Flumazenil
Chemical Name: Flumazenil
Molecular Formula: C15H14FN3O3
Formula Weight: 303.29
CAS No.: 78755-81-4
Description Review
Description

Flumazenil is a GABA antagonist which is mainly used to reverse the effect of benzodiazepines in the central nervous system. It is a cyclic imide and appears as a white to light yellow crystalline powder. Chemically, flumazenil is known as ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate. Its molecular formula is C15H14FN3O3 and has a molecular weight of 303.29 g/mol. Flumazenil has the CAS registry number of 78755-81-4.

Top ten keywords from Google on flumazenil are flumazenil reversal, flumazenil mechanism, flumazenil dosage, flumazenil mechanism of action, flumazenil pharmacology, flumazenil in benzodiazepine overdose, flumazenil uses, flumazenil drug, flumazenil side effects, and flumazenil administration. The synonyms of flumazenil include Anexate, Flumazenilo, Flumazenilum, Ro 15-1788, and Romazicon.

Flumazenil is mainly used for reversing the effects of benzodiazepines. Benzodiazepines are a class of drugs that are mainly used for anxiety disorders and insomnia. They work by enhancing the action of GABA (gamma-aminobutyric acid), which is a neurotransmitter that inhibits the activity of the central nervous system. Flumazenil acts as a competitive antagonist and binds to the benzodiazepine receptor, thereby blocking the effect of the benzodiazepines. It has a high affinity for the benzodiazepine receptor and rapidly reverses the effect of benzodiazepines.

In addition to reversing the effect of benzodiazepines, flumazenil has several other potential effects. Flumazenil is known to have a short half-life and has been shown to decrease the frequency of neonatal seizures in infants born from mothers who used benzodiazepines during pregnancy. It is also used as a diagnostic tool for evaluating suspected benzodiazepine overdoses. Flumazenil may be helpful in the treatment of hepatic encephalopathy in patients with cirrhosis of the liver. There is also some evidence suggesting that flumazenil may have a therapeutic potential in the treatment of post-operative cognitive dysfunction.

Flumazenil acts by binding to the benzodiazepine receptor and reversing the effect of benzodiazepines. The benzodiazepine receptor is a subtype of GABA receptor that is located on the surface of the postsynaptic neuron. When benzodiazepines bind to the receptor, they enhance the affinity of GABA for the receptor, thereby increasing the inhibition of the central nervous system. Flumazenil binds competitively to the benzodiazepine receptor, thereby blocking the effect of benzodiazepines. Flumazenil is rapidly absorbed when given intravenously and has a short half-life.

Flumazenil is generally considered to be safe and well-tolerated. The most common side effects include dizziness, headache, nausea, and vomiting. It may also cause anxiety, agitation, and hallucinations in some patients. Flumazenil should be used with caution in patients with a history of seizures, as it may lower the seizure threshold. It may also precipitate withdrawal symptoms in patients who are physically dependent on benzodiazepines.

The dosing information for flumazenil depends on the indication for use. For the reversal of benzodiazepine overdoses in adults, the recommended dose is 0.2 mg to 1.0 mg given intravenously over 15 seconds. The dose may be repeated every minute up to a maximum of 3 mg. In infants, the dose is 0.01 mg/kg given intravenously over 15 seconds, with a maximum dose of 0.2 mg. The dosing information for other indications may vary.

In conclusion, flumazenil is an important medication used for reversing the effect of benzodiazepines. It acts by binding to the benzodiazepine receptor and blocking the effect of benzodiazepines. Flumazenil has several other potential effects and may be helpful in the treatment of other conditions such as neonatal seizures, hepatic encephalopathy, and post-operative cognitive dysfunction. Flumazenil is generally safe and well-tolerated, although it may cause side effects in some patients. Flumazenil should be used with caution in patients with a history of seizures and in patients who are physically dependent on benzodiazepines. The dosing information for flumazenil depends on the indication for use and may vary. It is important to consult with a healthcare provider before using flumazenil.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code